Last Updated: June 22, 2026

DEXTROSE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dextrose, and when can generic versions of Dextrose launch?

Dextrose is a drug marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Miles, Otsuka Icu Medcl, Hospira, Abbott, Am Regent, DHL, Icu Medical Inc, and Intl Medication Sys. and is included in eighty-one NDAs.

The generic ingredient in DEXTROSE is dextrose; potassium chloride; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DEXTROSE?
  • What are the global sales for DEXTROSE?
  • What is Average Wholesale Price for DEXTROSE?
Summary for DEXTROSE
US Patents:0
Applicants:11
NDAs:81
Drug Prices: Drug price information for DEXTROSE
What excipients (inactive ingredients) are in DEXTROSE?DEXTROSE excipients list
DailyMed Link:DEXTROSE at DailyMed

US Patents and Regulatory Information for DEXTROSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa DEXTROSE 5% AND SODIUM CHLORIDE 0.9% dextrose; sodium chloride INJECTABLE;INJECTION 211211-001 Sep 14, 2020 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 016678-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate INJECTABLE;INJECTION 017484-001 Approved Prior to Jan 1, 1982 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Abbott DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 018055-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 5% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020179-001 Dec 7, 1992 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018037-003 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun DEXTROSE 60% dextrose INJECTABLE;INJECTION 017995-002 Sep 22, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.